Inici › Mieloma múltiple › Iowa › Cedar Rapids
Assaigs clínics de Mieloma múltiple a Cedar Rapids, IA
15 estudis de Mieloma múltiple busquen participants en centres de Cedar Rapids i voltants (en un radi d'uns 30 milles). Obre un estudi per veure qui hi pot participar i com contactar amb l'equip.
Text oficial de l'estudi (anglès)
A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
ReclutantFase 3
- University of Iowa Hospitals and Clinics, Iowa City · a 25 mi
A Phase I, Open-label, Multicenter Study to Evaluate the Safety, Tolerability, Cellular Kinetics, Immunogenicity, Pharmacodynamics, and Preliminary Efficacy of AZD0120 in Participants With Multiple Myeloma (DURGA-2)
ReclutantFase 1
- Research Site, Iowa City · a 25 mi
A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma
ReclutantFase 3
- University of Iowa Hospital and Clinics, Iowa City · a 25 mi
Collection of Tissue Samples for Cancer Research
ReclutantEstudi observacional
- University of Iowa, Iowa City · a 25 mi
Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma
ReclutantFase 2
- University of Iowa, Iowa City · a 25 mi
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
ReclutantFase 3
- Mercy Hospital, Cedar Rapids
- Oncology Associates at Mercy Medical Center, Cedar Rapids
AZD0120 in Relapsed/Refractory Multiple Myeloma (DURGA-1)
ReclutantFase 1/2
- Research Site, Iowa City · a 25 mi
Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT
ReclutantFase 3
- Research Site, Iowa City · a 25 mi
A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma
ReclutantFase 2
- University of Iowa, Iowa City · a 25 mi
Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
ReclutantFase 3
- Physicians' Clinic of Iowa PC, Cedar Rapids
- University of Iowa/Holden Comprehensive Cancer Center, Iowa City · a 25 mi
Frontline T-cell Engager vs Autologous Stem Cell Transplant (ASCT) and Measurable Residual Disease (MRD)-Guided Sequential Intensification thERapy in Multiple Myeloma
ReclutantFase 2
- University of Iowa, Iowa City · a 25 mi
Sirolimus Pre-conditioning on T Cell Activity and T-cell Engaging Bispecific Antibody Efficacy in Multiple Myeloma
ReclutantFase 1
- University of Iowa Health Care, Iowa City · a 25 mi
Sleep Apnea in Patients With MGUS and MM
ReclutantEstudi observacional
- University of Iowa, Iowa City · a 25 mi
Activity Levels in Bone Marrow Transplant Patients
ReclutantEstudi observacional
- University of Iowa, Iowa City · a 25 mi
Limited-duration Teclistamab
ReclutantFase 2
- University of Iowa Hospitals and Clinics, Iowa City · a 25 mi
Assaigs de Mieloma múltiple en altres ciutats
- New York City, NY60 estudis
- Boston, MA42 estudis
- Atlanta, GA41 estudis
- Houston, TX38 estudis
- Durham, NC37 estudis
- Nashville, TN32 estudis
- Denver, CO27 estudis
- Rochester, MN24 estudis
- St. Louis, MO24 estudis
- Columbus, OH24 estudis
- Baldwin Park, CA23 estudis
- Chicago, IL22 estudis
Altres estudis a Cedar Rapids
- Càncer de pulmó de cèl·lules no petites20 estudis
- Càncer de mama17 estudis
- Leucèmia mieloide aguda16 estudis
- Càncer (tots els tipus)15 estudis
- Càncer de pulmó14 estudis
- Càncer colorrectal13 estudis
- Càncer de pròstata12 estudis
- Carcinoma de cèl·lules escamoses de cap i coll12 estudis
- Melanoma10 estudis
- Ictus10 estudis
- Càncer metastàtic9 estudis
- Càncer d'endometri9 estudis
De ClinicalTrials.gov, dades recuperades el 5 d’oct. 2026. Cada estudi estableix els seus propis criteris d'elegibilitat; l'equip de l'estudi decideix qui hi pot participar.